63.31

2.73% 1.68

After Hours: 63.50 0.19 +0.30%

Viking Therapeutics Inc (VKTX)

Overview News Price History Option Chain Financials Why VKTX Down? Discussions Forecast

Viking Therapeutics Inc stock is traded at $63.31, with a volume of 2.01M. It is up +2.73% in the last 24 hours and down -1.26% over the past month. Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Previous Close:

$61.63

Open:

$61.9

24h Volume:

2.01M

Relative Volume:

0.54

Market Cap:

$6.96B

Revenue:

Net Income/Loss:

$-96.75M

P/E Ratio:

-68.08

EPS:

-0.93

Net Cash Flow:

$-71.95M

1W Performance:

-2.61%

1M Performance:

-1.26%

6M Performance:

-22.79%

1Y Performance:

+471.91%

1-Day Range:

$61.41

$64.55

1-Week Range:

$61.29

$65.61

52-Week Range:

$8.28

$99.41

Viking Therapeutics Inc Stock (VKTX) Company Profile

Name

Viking Therapeutics Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

858-704-4660

Address

9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA

Employee

Twitter

@viking_vktx

Next Earnings Date

2024-10-23

Latest SEC Filings

VKTX's Discussions on Twitter

Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-31-23	Resumed	ROTH MKM	Buy
Mar-28-23	Reiterated	Maxim Group	Buy
Mar-17-23	Initiated	Stifel	Buy
Jul-29-21	Resumed	BTIG Research	Buy
May-25-21	Downgrade	Raymond James	Strong Buy → Outperform
Jun-05-20	Initiated	BMO Capital Markets	Outperform
May-05-20	Initiated	Chardan Capital Markets	Buy
May-01-20	Initiated	BTIG Research	Buy
Jul-16-19	Initiated	Oppenheimer	Outperform
Jun-25-19	Initiated	Stifel	Buy
Mar-29-19	Upgrade	SVB Leerink	Mkt Perform → Outperform
Mar-14-19	Reiterated	Maxim Group	Buy
Feb-22-19	Initiated	SVB Leerink	Mkt Perform
Dec-12-18	Initiated	B. Riley FBR	Buy
Nov-19-18	Upgrade	Raymond James	Outperform → Strong Buy
Sep-18-18	Reiterated	H.C. Wainwright	Buy
Sep-18-18	Reiterated	Maxim Group	Buy
Sep-18-18	Reiterated	Raymond James	Outperform
Jul-20-18	Initiated	SunTrust	Buy
Jun-28-18	Initiated	Raymond James	Outperform
Jun-01-18	Reiterated	Laidlaw	Buy
May-31-18	Reiterated	Maxim Group	Buy
Mar-26-18	Resumed	H.C. Wainwright	Buy
Nov-28-17	Reiterated	Maxim Group	Buy
Nov-21-17	Initiated	ROTH Capital	Buy

View All

Viking Therapeutics Inc Stock (VKTX) Latest News

06:34 AM

Why Viking Therapeutics Stock Topped the Market Today - Yahoo! Voices

06:34 AM

02:36 AM

Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 1.9% - MarketBeat

02:36 AM

03:58 AM

Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Purchased by Hsbc Holdings PLC - MarketBeat

03:58 AM

Sep 29, 2024

Is Viking Therapeutics Stock a Buy? - sharewise

Sep 29, 2024

Is Viking Therapeutics Stock a Buy? - Yahoo Finance

Sep 29, 2024

Is Viking Therapeutics, Inc. (VKTX) the Best Performing Long Term Stock in 2024? - Insider Monkey

Sep 29, 2024

Is Viking Therapeutics, Inc. (VKTX) the Best Performing Long Term Stock in 2024? - Yahoo Finance

Sep 29, 2024

Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Sep 29, 2024

Sep 28, 2024

Blue Owl Capital Holdings LP Makes New $5.04 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat

Sep 28, 2024

Sep 27, 2024